← Back to Clinical Trials
RecruitingNCT06167135

Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) Cohort

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionInfertility, Female
SponsorSemmelweis University
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment150
SexFEMALE
Min Age20 Years
Max Age45 Years
Start Date2021-09-10
Completion2033-09-30

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Enrolling of 150 female patients of fertile age diagnosed with PCOS, insulin resistance, infertility, or mitochondrial disease, and the same number of age- and sex-matched controls are planned. During the research biomarkers already with mitochondrial dysfunction in the scientific literature and common mtDNA abnormalities (deletions, point mutations, copy number changes, etc.) are examined.

Eligibility Criteria

Inclusion Criteria: * Presence of polycystic ovary syndrome (PCOS) or insulin resistance (IR) associated with other multisystemic phenotypes, mitochondrial dysfunction * history of infertility associated with other multisystemic phenotypes, mitochondrial dysfunction * a known history of mitochondrial dysfunction and PCOS and/or IR * general health is good and there is no serious general medical condition that would prevent participation would make participation highly risky Exclusion Criteria: * poor cooperation * refusal to participate in the study

Related Trials